Lymphocytopenia
Conditions
Interventions
Control group:None
Sponsors
The Second Affiliated Hospital of the Army Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1.Pelvic tumor patients; 2.Age >=18 and <= 60 years old; 3.Sign the informed consent form, fully understand and comply with the requirements of the research protocol, and be willing to complete the study as planned.
Exclusion criteria
Exclusion criteria: 1.Irradiated the thymus; 2.Stem cell transplantation (including stem cell reinfusion); 3.Abnormal coagulation function, defined as any of the following parameters exceeding the normal range: prothrombin time, activated partial thromboplastin time, thrombin time, or fibrinogen; 4.History of lymphatic system disorders, including but not limited to acute lymphoblastic leukemia, chronic lymphocytic leukemia, lymphoma, multiple myeloma, and splenomegaly; 5.Combined infectious diseases, including but not limited to influenza, typhoid fever, pulmonary infections, and skin infections; 6.Any reason that prevents participation in the study or if the investigator deems the subject unsuitable for inclusion in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lymphocyte count; | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression-Free Survival;Occurrence, severity, timing, and duration of other adverse events (AEs);Overall survival; | — |
Countries
China
Contacts
Public ContactZhongjun Li
The Second Affiliated Hospital of the Army Medical University
Outcome results
None listed